Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FC7HH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,593
Award facts
- Contract value 100% obligated
- $14,592.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,592.57 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Vyndamax 61 mg capsule units (30-count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of February 3, 2026, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vyndamax is a specialty pharmaceutical used in the treatment of transthyretin amyloidosis, a rare genetic disorder, indicating this delivery order supports the Defense Logistics Agency's Medical Supply Chain in providing specialized therapeutic medications to military healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC serves as the primary vehicle for supplying a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities—to support military healthcare programs globally. AmerisourceBergen's federal contract portfolio demonstrates consistent capability in competitively awarded pharmaceutical procurement across multiple therapeutic domains for military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FC7HH?
SPE2DR26FC7HH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FC7HH worth?
The government has obligated $14,593 on SPE2DR26FC7HH.
Is contract SPE2DR26FC7HH an order under another contract?
Yes. SPE2DR26FC7HH is a delivery order under SPE2DR25D2217, an indefinite delivery contract.
Was contract SPE2DR26FC7HH competed?
The extent of competition for SPE2DR26FC7HH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award